Brand Name: ESOHELP
Generic Name: Esomeprazole magnesium Delayed- Release Capsules USP
Available Strengths:
Esomeprazole magnesium Delayed- Release Capsules USP 20mg/40mg
Esomeprazole Delayed-Release (DR) Capsules are advanced proton pump inhibitors (PPIs) formulated to manage acid-related gastrointestinal conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and peptic ulcers. The delayed-release formulation ensures the active ingredient bypasses the stomach and dissolves in the intestine, enhancing bioavailability and therapeutic effect. Esomeprazole works by selectively inhibiting proton pumps in the stomach lining, reducing acid secretion and promoting healing of the gastrointestinal mucosa. Manufactured under stringent quality standards, these capsules provide consistent, fast, and long-lasting relief from acid reflux, heartburn, and gastric discomfort when taken as directed by a healthcare professional.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com